| Subaltern urbanisation in India E Denis, MH Zérah, P Mukhopadhyay Springer, 2017 | 321 | 2017 |
| A comparative analysis of efficiency and productivity of the Indian pharmaceutical firms: a malmquist-meta-frontier approach M Mazumdar, M Rajeev Bangalore, India, 2009 | 71 | 2009 |
| Performance of pharmaceutical companies in India: a critical analysis of industrial structure, firm specific resources, and emerging strategies M Mazumdar Springer Science & Business Media, 2012 | 46 | 2012 |
| Output and input efficiency of manufacturing firms in India: A case of the Indian pharmaceutical sector M Mazumdar, M Rajeev, SC Ray Bangalore, India, 2009 | 28 | 2009 |
| An overview of the Indian pharmaceutical sector M Mazumdar, M Mazumdar Performance of pharmaceutical companies in India: A critical analysis of …, 2013 | 16 | 2013 |
| The sources of heterogeneity in the efficiency of Indian pharmaceutical firms M Mazumdar, M Mazumdar Performance of Pharmaceutical Companies in India: A Critical Analysis of …, 2013 | 15 | 2013 |
| Innovation, firm size and ownership: a study of firm transition in India S Agrawal, P Singh, M Mazumdar International Journal of Global Business and Competitiveness 16 (1), 15-27, 2021 | 10 | 2021 |
| On price discrimination, parallel trade and the availability of patented drugs in developing countries M Mazumdar, DS Banerjee International Review of Law and Economics 32 (1), 188-195, 2012 | 9 | 2012 |
| Growth, regional disparity and convergence clubs in India: A sectoral level analysis and decomposition B Chaudhuri, M Mazumdar, M Teachout, V Marimoutou 32nd general conference of the International Association for Research in …, 2012 | 8 | 2012 |
| Income ranking of Indian states and their pattern of urbanisation B Chaudhuri, B Chatterjee, M Mazumdar, S Karim Subaltern Urbanisation in India: An Introduction to the Dynamics of Ordinary …, 2017 | 6 | 2017 |
| Modeling signed networks as 2-layer growing networks PK Pandey, B Adhikari, M Mazumdar, N Ganguly IEEE Transactions on Knowledge and Data Engineering 34 (7), 3377-3390, 2020 | 5 | 2020 |
| TRIPS agreement and the emerging in-house R&D activity of the Indian pharmaceutical companies: A panel data analysis of the firm level data M Majumder, M Rajeev PES Business Review, 3-23, 2008 | 5 | 2008 |
| Profitability of Indian Pharmaceutical Firms M Mazumdar, M Mazumdar Performance of Pharmaceutical Companies in India: A Critical Analysis of …, 2013 | 2 | 2013 |
| Product patent, the problem of availability of patented drugs and parallel trade: A theoretical approach M Mazumdar, M Rajeev Journal of World Intellectual Property 13 (4), 581-604, 2010 | 2 | 2010 |
| Strategic network formation involving social relations: Enmity and friendship D Pal, B Adhikari, M Mazumdar 2015 7th International Conference on Communication Systems and Networks …, 2015 | 1 | 2015 |
| Sources of heterogeneity in the efficiency of Indian pharmaceutical firms S Ray, M Mazumdar, M Rajeev eSocialSciences, 2010 | 1 | 2010 |
| 4 Comparing the Efficiency of the Indian Pharmaceutical Firms: A Meta-Frontier Approach M Mazumdar, M Rajeev Indian Economic Journal 57 (4), 60, 2010 | 1 | 2010 |
| Comparing the Efficiency of the Indian Pharmaceutical Firms: A Meta-Frontier Approach M Mazumdar, M Rajeev The Indian Economic Journal 57 (4), 60-83, 2010 | 1 | 2010 |
| Firm Transitions in Indian Formal MSMEs S Agrawal, P Singh, M Mazumdar, KV Ramaswamy Economic & Political Weekly 57 (43), 53, 2022 | | 2022 |
| Firm Transition in Indian MSMEs: The Role of Govt Assistance, Finance, Innovation on Firm Transition and Its Impact on the Productivity Differences and Productivity of the Firms M Mazumdar, S Agarwal, P Singh | | 2021 |
